Hong Kong · Delayed Price · Currency is HKD The United Laboratories International Holdings Company Description
The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin products; insulin series, antibiotics, and ophthalmic products; and veterinary drugs.
It also provides 6-aminopenicillanic acid and penicillin G potassium products. In addition, the company provides endocrine and metabolism, anti-infection, and other human-used finished products, including ophthalmic drugs, topical dermatological drugs, etc.; and health and wellness products, such as general dietary supplements, healthcare food products, cross-border nutritional supplements, and medical and aesthetic skincare products for various categories comprising bone and joint nutrition, intestinal regulation, cardiovascular health, vision protection, and immunity enhancement.
Further, it is involved in the research and development, production, sale, and technical services of economic and companion animal medicines for livestock, poultry, and aquatic products and pets.
The company has operations in the People's Republic of China, India, Europe, the Middle East, South America, rest of Asian regions, and internationally.
The United Laboratories International Holdings Limited was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
| Country | Cayman Islands |
| Founded | 1990 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 18,000 |
Contact Details
Address: 6 Fuk Wang Street Yuen Long Hong Kong | |
| Phone | 852 2687 1033 |
| Website | tul.com.cn |
Stock Details
| Ticker Symbol | 3933 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG8813K1085 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hoi Shan Tsoi | Executive Chairman |
| Wing Hon Leung CPA, FCPA | Vice Chairman, Chief Financial Officer and Company Secretary |
| Xian Hong Zou | Vice President and Executive Director |
| Siu Chit Choy | Global Director of Intermediate and Bulk Medicine and Executive Director |
| Yu Ping Fang | Vice President and Executive Director |
| Karen Yang | Investor Relationship Director |
| Wen Yu Zhang | General Manager of United Laboratories (Inner Mongolia) Limited |
| Yu Bo Han | General Manager of Zhuhai United Laboratories Co., Ltd |
| Chun Lai Cao | General Manager of United Bio-Technology (Hengqin) Co., Ltd |